Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Donald A Mahler, Henrik Watz, Rachel Emerson-Stadler, John Ritz, Asparuh Gardev, Asif Shaikh & M Bradley Drummond. (2023) Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1729-1740.
Read now
Read now
Ville A Vartiainen, Federico Lavorini, Anna C Murphy & Klaus F Rabe. (2023) High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD. Expert Opinion on Drug Delivery 20:3, pages 385-393.
Read now
Read now
Marika T Leving, Job FM van Boven, Sinthia Z Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Marina García Pardo, Asparuh Gardev, Radosław Gawlik, Iris van der Ham, Elisabeth Sophia Hartgers-Gubbels, Ymke Janse, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David B Price, Miguel Roman-Rodríguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar S Usmani & Janwillem H Kocks. (2022) Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2401-2415.
Read now
Read now
Brendan Clark, Brian J Wells, Amit K Saha, Jessica Franchino-Elder, Asif Shaikh, Bonnie M K Donato & Jill A Ohar. (2022) Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1483-1494.
Read now
Read now
Donald A Mahler, Xiaoli Niu, Kathleen L Deering & Carole Dembek. (2022) Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 559-568.
Read now
Read now
Jill A Ohar, Gary T Ferguson, Donald A Mahler, M Bradley Drummond, Rajiv Dhand, Roy A Pleasants, Antonio Anzueto, David M G Halpin, David B Price, Gail S Drescher, Haley M Hoy, John Haughney, Michael W Hess & Omar S Usmani. (2022) Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 79-92.
Read now
Read now
Alpesh N. Amin, Sharon Cornelison, J. Andrew Woods & Nicola A. Hanania. (2022) Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgraduate Medicine 134:2, pages 152-159.
Read now
Read now
Donald A Mahler, Andrea Ludwig-Sengpiel, Gary T Ferguson, Alberto de la Hoz, John Ritz, Asif Shaikh & Henrik Watz. (2021) TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2455-2465.
Read now
Read now
Nan Ding, Wei Zhang, Zhuo Wang, Chong Bai, Qian He, Yuchao Dong, Xiumin Feng, Jingxi Zhang & Shen Gao. (2021) Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1913-1924.
Read now
Read now
Martin Anderson, Kathryn Collison, M Bradley Drummond, Melanie Hamilton, Renu Jain, Neil Martin, Richard A Mularski, Mike Thomas, Chang-Qing Zhu & Gary T Ferguson. (2021) Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 933-943.
Read now
Read now
Collin M Clark, David M Jacobs & Sanjay Sethi. (2020) Revefenacin for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 14:3, pages 239-247.
Read now
Read now
Articles from other publishers (27)
Yixing Wu & Jing Zhang. (2023) Standardized inhalation capability assessment: A key to optimal inhaler selection for inhalation therapy. Journal of Translational Internal Medicine 11:1, pages 26-29.
Crossref
Crossref
Tamas Erdelyi, Zsofia Lazar, Árpád Farkas, Peter Furi, Attila Nagy & Veronika Müller. (2023) Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study. Frontiers in Medicine 10.
Crossref
Crossref
Hiroshi Ohnishi, Masafumi OkazakiKazuki AnabukiShin AkitaShigeo KawaseKimiko Sakai TsujiMitsuhiko MiyamuraAkihito Yokoyama. (2023) An Investigation into the Factors Associated with Incorrect Use of a Pressurized Metered-Dose Inhaler in Japanese Patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery 36:1, pages 12-19.
Crossref
Crossref
Melanie Hamilton, Martin AndersonRajiv Dhand, Oonagh PatmoreDavid PrimeEdward Taylor. (2023)
In Vitro
Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler
. Journal of Aerosol Medicine and Pulmonary Drug Delivery 36:1, pages 34-43.
Crossref
Crossref
Apisara Suriyakul, Narongkorn Saiphoklang, Igor Barjaktarevic & Christopher B. Cooper. (2022) Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease. Diagnostics 12:12, pages 3050.
Crossref
Crossref
Esra Yıldız Bölükbaşı, Justyna A. Karolak, Przemyslaw Szafranski, Tomasz Gambin, Nicholas Willard, Steven H. Abman, Csaba Galambos, John P. Kinsella & Paweł Stankiewicz. (2022)
High‐level gonosomal mosaicism for a pathogenic non‐coding
CNV
deletion of the lung‐specific
FOXF1
enhancer in an unaffected mother of an infant with
ACDMPV
. Molecular Genetics & Genomic Medicine 10:11.
Crossref
Crossref
Blake R. Johnson, Andrea S. Franks, Laura N. Bullock, Danielle L. Dennis, R. Eric Heidel & Timothy H. Self. (2022) Pharmacist‐led inhaler training for nurses on an acute care pulmonary unit. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:7, pages 660-667.
Crossref
Crossref
Janwillem W. H. Kocks, Hans Wouters, Sinthia Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Evgeni Dvortsin, Marina Garcia Pardo, Asparuh Gardev, Radosław Gawlik, Iris van Geer - Postmus, Iris van der Ham, Marten Harbers, Alberto de la Hoz, Ymke Janse, Marjan Kerkhof, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David Price, Miguel Roman-Rodriguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar Usmani & Marika T. Leving. (2022) Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers. npj Primary Care Respiratory Medicine 32:1.
Crossref
Crossref
Jeffry Weers. (2022) Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?. Frontiers in Drug Delivery 2.
Crossref
Crossref
Malik M. Khurram S. Khan, Adam G. Cole & David M. Mannino. (2022) Precision medicine in chronic obstructive pulmonary disease: how far have we come?. Current Opinion in Pulmonary Medicine 28:2, pages 115-120.
Crossref
Crossref
Marika T. Leving, Janwillem Kocks, Sinthia Bosnic-Anticevich, Richard Dekhuijzen & Omar S. Usmani. (2022) Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD—A Systematic Scoping Review. Biomedicines 10:2, pages 458.
Crossref
Crossref
Jian-lan Hua, Xiao-fen Ye, Chun-ling Du, Ning Xie, Jie-qing Zhang, Man Li & Jing Zhang. (2021) Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Alfredo Chetta, Arzu Yorgancioglu, Mario Scuri, Sara Barile, Daniele Guastalla & P. N. Richard Dekhuijzen. (2021) Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Marika Leving, Hans Wouters, Alberto de la Hoz, Sinthia Bosnic-Anticevich, Richard Dekhuijzen, Asparuh Gardev, Federico Lavorini, Jiska Meijer, David Price, Miguel Román Rodríguez, Ioanna Tsiligianni, Omar Usmani, Birgit Wijnsma & Janwillem Kocks. (2021) Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study). Pulmonary Therapy 7:2, pages 591-606.
Crossref
Crossref
Clarence Baxter, Julie-Anne Carroll, Brendan Keogh & Corneel Vandelanotte. (2021) Seeking Inspiration: Examining the Validity and Reliability of a New Smartphone Respiratory Therapy Exergame App. Sensors 21:19, pages 6472.
Crossref
Crossref
Donald A. Mahler & David M.G. Halpin. (2021) Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD. Chest 160:2, pages 491-498.
Crossref
Crossref
Shih-Yu Chen, Chun-Kai Huang, Hui-Chuan Peng, Hsing-Chen Tsai, Szu-Ying Huang, Chong-Jen Yu & Jung-Yien Chien. (2021) Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD. Frontiers in Pharmacology 12.
Crossref
Crossref
Ramesh Chokhani, Abdul Razak Muttalif, Kirthi Gunasekera, Aniruddha Mukhopadhyay, Vaibhav Gaur & Jaideep Gogtay. (2021) Understanding Practice Patterns of COPD: A Survey of Physicians in Nepal, Sri Lanka and Malaysia. Pulmonary Therapy 7:1, pages 251-265.
Crossref
Crossref
Manuel Castro Barrio, Eva M.ª Sanz Peces & Nuria M. Martínez Gordillo. (2021) Dispositivos para inhalación en personas con baja capacidad inhalatoria-ancianos. FMC - Formación Médica Continuada en Atención Primaria 28:5, pages 286-288.
Crossref
Crossref
Deepak Talwar, R Ramanathan, Meena Lopez, Rashmi Hegde, Jaideep Gogtay & Geeta Goregaonkar. (2021) The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home. Lung India 38:2, pages 168.
Crossref
Crossref
Z. R. Aisanov, V. V. Arkhipov, S. N. Avdeev, V. N. Antonov, I. V. Demko, А. V. Zhestkov, K. A. Zykov, I. V. Leshchenko, L. B. Postnikova, A. I. Sinopal’nikov, O. N. Titova, E I. Shmelev & E. А. Shabanov. (2020) Suboptimal peak inspiratory flow rate in COPD patients: the importance of assessment in clinical practice. Expert Council Consensus. PULMONOLOGIYA 30:6, pages 805-811.
Crossref
Crossref
Cristina Represas-Represas, Luz Aballe-Santos, Alberto Fernández-García, Ana Priegue-Carrera, José-Luis López-Campos, Almudena González-Montaos, Maribel Botana-Rial & Alberto Fernández-Villar. (2020) Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD. Journal of Clinical Medicine 9:12, pages 3949.
Crossref
Crossref
Christian Taube, Valentina Bayer, Christoph Michael Zehendner & Arschang Valipour. (2020) Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice. Pulmonary Therapy 6:2, pages 371-380.
Crossref
Crossref
Jill A. Ohar, Andrea Bauer, Sanjay Sharma & Shahin Sanjar. (2020) In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®. Pulmonary Therapy 6:2, pages 289-301.
Crossref
Crossref
Shih-Yu Chen, Chun-Kai Huang, Hui-Chuan Peng, Chong-Jen Yu & Jung-Yien Chien. (2020) Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease. Scientific Reports 10:1.
Crossref
Crossref
Hadeer S. Harb, Nabila Ibrahim Laz, Hoda Rabea & Mohamed E.A. Abdelrahim. (2020) Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients. European Journal of Pharmaceutical Sciences 147, pages 105298.
Crossref
Crossref
Roy A. Pleasants, Peter A. Radlowski & H. Edward Davidson. (2019) Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting. Drugs & Aging 36:8, pages 733-745.
Crossref
Crossref